Human-centric preclinical models for CAR T cell therapy in solid tumors: Where patient-derived...
Chimeric antigen receptor (CAR) T cell therapy has shown promising activity in solid tumors, yet translational progress remains limited by preclinical models that incompletely capture human tumor...
cell.com